Parexel

Parexel updates Perceptive MyTrials Platform

Friday, July 24, 2015

Global CRO Parexel International launched the next generation of its Perceptive MyTrials platform with advanced analytics capabilities. With the Perceptive MyTrials Analytics solution, clinical trial sponsors now can use a mobile-enabled, single entry-point to access predictive data analytics for multiple studies simultaneously. The solution offers real-time and aggregated analytics allowing sponsors and Parexel clinical research professionals to detect key signals and trends. The Perceptive MyTrials Analytics solution also offers cross-sponsor viewing options for clients who need to evaluate data from multiple sponsors.

[Read More]

Parexel expands model-based drug development offering

Friday, July 10, 2015

Global CRO Parexel International has launched expanded services and capabilities in model-based drug development (MBDD) through its Quantitative Clinical Development (QCD) group.  The Parexel QCD team also offers leadership in all strategic and quantitative aspects of clinical pharmacology for biopharmaceutical companies to help expedite drug development, minimize risk and support regulatory approval processes.

[Read More]

Parexel to cut 850 jobs

Friday, June 26, 2015

Parexel International has updated its forward-looking guidance for the fourth quarter of Fiscal Year 2015 (ending June 30) and for the full Fiscal Year 2015. The company expects to restructure the company, cutting 850 positions.

[Read More]

inVentiv Health names Michael McKelvey EVP, Clinical division president

Friday, June 5, 2015

Global CRO inVentiv Health has appointed Michael McKelvey, Ph.D., president, inVentiv Health Clinical Division, and executive vice president, inVentiv Health. McKelvey is a seasoned veteran within the CRO industry and has a strong background in clinical development, technology and the development of innovative industry strategies. McKelvey has extensive experience in building and managing successful global organizations in the pharmaceutical services, healthcare, information technologies, life sciences, technology and global core laboratory industries.  

[Read More]

Parexel enhances ClinPhone RTSM service

Wednesday, May 27, 2015

Global CRO Parexel International has launched enhancements to its Randomization and Trial Supply Management (RTSM) service, ClinPhone RTSM. Parexel designed the enhanced service to simplify patient randomization and clinical supply management and to offer greater speed and flexibility in tailoring the service to meet the needs of clinical trials, while reducing delivery timelines. For the improvements, Parexel integrated the interactive response technology acquired from ClinIntel in October 2014 with Parexel’s experience in delivering RTSM services to thousands of studies to create an enhanced fourth-generation technology platform.

[Read More]

Parexel wins 2015 Clinical Innovator of the Year Award

Friday, April 24, 2015

Partnerships in Clinical Trials has named Parexel‘s Drew Garty, senior director, product management, the 2015 Clinical Innovator of the Year. The award recognizes Garty’s leadership of the product development team for the company’s Perceptive MyTrials Data-Driven Monitoring solution.

[Read More]